Mebendazole and Ivermectin in Integrative Oncology: A Rigorous Evidence-Based Evaluation of Repurposed Antiparasitic Agents in Cancer Care
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician July 2026 ⚠ IMPORTANT MEDICAL DISCLAIMER This article is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Neither mebendazole nor ivermectin is FDA-approved for any oncologic indication. The